HPV vaccine study targets key communities to boost protection
NCT ID NCT06588257
First seen May 15, 2026 · Last updated May 15, 2026
Summary
This study looked at how willing transgender women and men who have sex with men are to get the HPV vaccine. About 100 participants were offered the vaccine and followed for a year. The goal was to see how many started and completed the three-dose series, and to track anal HPV infections over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fundación Huésped
Ciudad Autónoma de Buenos Aires, Buenos Aires, C1427CEA, Argentina
Conditions
Explore the condition pages connected to this study.